FYN and breast carcinoma: FYN causes tamoxifen resistance in breast cancer (ER+), and knockdown of FYN expression or use of FYN inhibitors significantly inhibits the growth of tamoxifen-resistant cells and the association with poor prognosis in breast cancer [37].